Max Robotics — Global Service Robot Directory + US Certification

About

Ehab Billatos is a pioneering researcher at the intersection of soft robotics and interventional pulmonology, whose work is reshaping the diagnosis and treatment of lung cancer—the world’s leading cause of cancer death. His primary research areas include soft robotic systems for minimally invasive surgery, peripheral lung cancer diagnostics, and autonomous navigation for bronchoscopy. Billatos’s major contributions lie in developing millimeter-scale soft robots capable of safely navigating the delicate, branching airways of the lung periphery—a region traditionally inaccessible to rigid bronchoscopes. His landmark 2021 study, “A Soft Robot for Peripheral Lung Cancer Diagnosis and Therapy” (52 citations), introduced a novel approach to reaching and biopsying deep lung nodules, directly addressing a critical gap in early cancer detection. Building on this, his 2023 work on a millimeter-scale soft robot for tissue biopsy (43 citations) overcame key force-transmission limitations of soft surgical tools. More recently, Billatos has advanced the field with a real-time, semi-autonomous navigation platform (2025), promising to enhance precision and reduce procedure time. His work has been validated through multicenter prospective studies, demonstrating the clinical readiness of his biopsy assessment systems. With a growing citation impact and a clear trajectory toward autonomous, soft-robotic bronchoscopy, Billatos is a leading voice in the fight to make lung cancer diagnosis safer, more accurate, and more accessible.